Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month

• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible • New offering helps employers meet growing ...

May 21, 25

New Evernorth EnReachRx model expands its suite of GLP-1 solutions, works to improve patient outcomes and drive value

May 02, 25

Podcast: Understanding GLP-1 market challenges and actionable strategies for managing impact

Listen to the latest episode of the Health Unscripted Podcast for a deep dive into the challenges and opportunities within the GLP-1 landscape.

April 22, 25

Pharmacy in Focus: Navigating GLP-1 cost, demand and sustainability

With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.

March 25, 25

Coupling GLP-1 weight loss with mental health support

Learn about the behavioral health considerations that employers should be mindful of when it comes to GLP-1 users.

Douglas Nemecek, MD, MBA, June 12, 24

Evernorth chief bullish on driving affordability through biosimilars and access through guided care

May 08, 24